Danahy Kevin Patrick sold PLSE

February 9, 2026 · Form 4 insider transaction

Danahy Kevin Patrick sold 20,000 shares of Pulse Biosciences, Inc. at $21.45 per share, a transaction worth $429.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
20,000
Price
$21.45
Total value
$429.0K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after43,298
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025.; The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $21.00 to $23.22 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR